-
公开(公告)号:EP4067493A1
公开(公告)日:2022-10-05
申请号:EP22159835.2
申请日:2017-05-11
申请人: Amgen Inc.
摘要: This invention relates to the general field of recombinant expression of polypeptides in animal cell culture. More specifically, the invention concerns improved selection of cells transfected with recombinantly engineered vectors designed to express polypeptides, in particular heteromultimeric polypeptides.